Catalyst Wire Dossier Catalyst Wire Dossier

IONIS-TTR Rx

IONIS-TTR Rx · Ionis Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IONIS-TTR Rx, covering 2023-02-09 to 2023-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Extension Study Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP) [Phase 3]

See pricing